Sandra Boenisch compensation by year
ANAVEX LIFE SCIENCES Summary Compensation Table · all 9 fiscal years held| Component | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Salary | $71,800 | $79,608 | $72,327 | $117,041 | $158,300 | $174,900 | $186,883 | $201,468 | $199,858 |
| Bonus | $0 | $11,414 | $13,561 | $22,313 | $0 | $0 | $0 | $0 | $37,709 |
| Stock awards | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Option awards | $177,800 | $141,047 | $138,672 | $155,864 | $724,314 | $277,603 | $306,700 | $192,700 | $308,200 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $0 | $0 | $0 | $7,475 | $8,059 | $9,503 |
| Total | $249,600 | $232,069 | $224,560 | $295,218 | $882,614 | $452,503 | $501,058 | $402,227 | $555,270 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ANAVEX LIFE SCIENCES CORP. DEF 14A filed August 11, 2026, accession 0001731122-26-001038, and prior-year filings. Open the filing on EDGAR.
How this page was built: the ANAVEX LIFE SCIENCES CORP. filed document, accession 0001731122-26-001038. Every figure is read from that document and cited to the page and table it appears in. Filed August 11, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 37,500 | — | $8.58 |
| Option | 25,000 | — | $8.57 |
| Option | 40,000 | — | $18.11 |
| Option | 37,500 | — | $5.36 |
| Option | 20,000 | — | $10.09 |
Per the Outstanding Equity Awards at Fiscal Year-End table in ANAVEX LIFE SCIENCES CORP.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
4 Form 4 lines since the FY2025 proxy (filed August 11, 2026)current to 2026-11-10 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-24 | Grant or award derivative | — | 25,000 | $0.00 | 25,000 |
| 2026-09-24 | Grant or award derivative | — | 20,000 | $0.00 | 20,000 |
| 2026-09-24 | Grant or award derivative | — | 25,000 | $0.00 | 25,000 |
| 2026-09-24 | Grant or award derivative | — | 25,000 | $0.00 | 25,000 |
The 4 most recent of 4 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Change-in-control & termination
estimated payments ANAVEX LIFE SCIENCES discloses, by trigger · FY2024| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control, no termination | — | $16,000 | — | $16,000 |
Per the Potential Payments Upon Termination or Change in Control table in ANAVEX LIFE SCIENCES CORP.'s FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.
ANAVEX LIFE SCIENCES’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Missling | Chief Executive Officer | $3,959,085 |
| Sandra Boenisch · this page | Principal Financial Officer | $555,270 |
Sandra Boenisch's compensation dossier, ANAVEX LIFE SCIENCES
You have read Sandra Boenisch's totals and holdings. The dossier adds each equity grant ANAVEX LIFE SCIENCES disclosed for Sandra Boenisch and ANAVEX LIFE SCIENCES's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full ANAVEX LIFE SCIENCES compensation record
free company briefThis page is one person within ANAVEX LIFE SCIENCES's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order ANAVEX LIFE SCIENCES's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ANAVEX LIFE SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order AVXL
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.